Kalaris Therapeutics, Inc. (KLRS)
NASDAQ: KLRS · Real-Time Price · USD
2.900
-0.060 (-2.03%)
At close: May 30, 2025, 4:00 PM
3.040
+0.140 (4.83%)
After-hours: May 30, 2025, 4:02 PM EDT
Kalaris Therapeutics Market Cap
Kalaris Therapeutics has a market cap or net worth of $54.24 million as of May 30, 2025.
Market Cap
54.24M
Enterprise Value
-46.73M
1-Year Change
n/a
Ranking
Category
Stock Price
$2.90
Market Cap Chart
Since March 19, 2025, Kalaris Therapeutics's market cap has decreased from $214.52M to $54.24M, a decrease of -74.72%. That is a compound annual growth rate of -99.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 30, 2025 | 54.24M | -74.72% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 644.98B |
| Johnson & Johnson | 368.78B |
| AbbVie | 327.46B |
| Novo Nordisk | 305.07B |
| UnitedHealth Group | 269.77B |
| Abbott Laboratories | 231.28B |
| Novartis AG | 219.70B |
| AstraZeneca | 216.88B |